NASDAQ: NIKI

Niki BioSolutions, Inc.

CIK 0001734005 · SIC 3829 · Measuring & Controlling Devices

Micro Revenue $431K Assets $19M as of Aug 30, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (NX 10-Q) is open in full — no account needed.

8-K Filed Sep 4, 2026 · Period ending Sep 4, 2026

Summary not yet generated.

8-K Filed Aug 21, 2026 · Period ending Aug 21, 2026

Summary not yet generated.

Partner

Trade NIKI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Aug 7, 2026 · Period ending Aug 7, 2026

Summary not yet generated.

8-K Filed Jul 20, 2026 · Period ending Jul 20, 2026

Summary not yet generated.

424B3 Filed Jun 4, 2026 Red flag

Aptorum Group registers resale of up to 2.06M Class A shares from warrant exercises; company may receive up to $4.15M if warrants are cash-exercised

8 material changes detected. Sign up free to read the summary.

View report
424B5 Filed Dec 5, 2025

Summary not yet generated.

424B5 Filed Oct 14, 2025

Summary not yet generated.

424B5 Filed Jan 3, 2025

Summary not yet generated.

424B4 Filed May 25, 2021

Summary not yet generated.

424B4 Filed Oct 1, 2020

Summary not yet generated.

424B3 Filed Nov 26, 2019

Summary not yet generated.

424B3 Filed Oct 31, 2019

Summary not yet generated.

424B4 Filed Dec 4, 2018

Summary not yet generated.

View all filings for NIKI on SEC EDGAR